The London position statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organisation: safety.

This paper in the series from the World Congress of Gastroenterology addresses the safety and immunogenicity of biological therapy. The safety profile in randomized controlled studies of all biological agents in Crohn's disease (CD) and ulcerative colitis has been generally favorable, but a sma...

Descripció completa

Dades bibliogràfiques
Autors principals: Van Assche, G, Lewis, J, Lichtenstein, G, Loftus, E, Ouyang, Q, Panes, J, Siegel, C, Sandborn, W, Travis, S, Colombel, J
Format: Journal article
Idioma:English
Publicat: 2011